Business digest
Global pharma major AstraZeneca is collaborating with UK biotechnology company Silence Therapeutics to discover, develop and commercialise small interfering RNA (siRNA) therapeutics for cardiovascular, renal, metabolic and respiratory diseases.
Business digest
Spanish multinational pharmaceutical and chemical manufacturer Grifols is buying three ciprofloxacin-based assets from bankrupt US antibiotics developer Aradigm for $3m.
Bruising results for BASF
German chemicals giant BASF saw both sales and profits decline in 2019 as its upstream chemical businesses suffered.
Cutting corners?
Alexios Chronis, from CSols, examines if it is possible to cut corners when adopting a new informatics implementation project
Business digest
UK life science company Abcam, headquartered in Cambridge, and University College London spinout SomaServe have joined forces to commercialise the latter’s polymer-based ‘bioic’ nanoparticles which can carry a range of products to live cells.
Quality from LIMS
Trish Meek & Abigail Orozco from Thermo Fisher Scientific describe how a LIMS improved quality and regulatory compliance at a Chilean oil and gas supplier
Business digest
US biotechnology company Exicure has entered into a collaboration with Allergan Pharmaceuticals International, a subsidiary of Ireland-headquartered pharmaceutical company Allergan.
Business digest
Japanese pharmaceutical company Astellas Pharma and US-based bioelectronics start-up iota Biosciences have entered into a collaborative R&D agreement.
Filling the promethium gap
One hundred and fifty years ago, the Russian chemist Dmitri Mendeleev proposed a ‘system of elements’ ordering the known chemical elements according to their atomic weights and chemical properties.